Robert Van de Mark
Lawyers
Filters
Talawar Therapeutics $225 million PIPE financing and de-SPAC transaction
We advised the placement agents on the transaction
GH Research $200 million at-the-market offering
We advised GH Research on the establishment of the at-the-market program
JATT II Acquisition $60 million SPAC IPO
We advised the sole bookrunning manager in connection with the IPO
Emera $750 million senior notes offering
We advised Emera on its offering
Emera $750 million fixed-to-fixed reset rate junior subordinated notes offering
We advised Emera on its offering
Tandem Diabetes Care $300 million convertible senior notes offering
We advised the representatives of the initial purchasers on the offering
General Motors Financial $1.5 billion senior notes offering
We advised the underwriters on the offering
Terns Pharmaceuticals $747.5 million stock offering
We advised the underwriters on the public offering
Emera C$600 million at-the-market offering
We advised Emera on the offering
ExxonMobil $112 million notes offering
We advised ExxonMobil on the investment-grade debt offering